We previously established that PTPN13 mRNA expression level is an independent prognostic indicator of favorable outcome for patients with breast cancer 23, and that PTPN13 protein levels are decreased in primary and metastatic breast cancer compared with normal breast tissue 13. This evidence concerns the gene PTPN13 and breast cancer.